| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.57 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |